Table 1. The characteristics of the EC patients.

circTNFRSF21			miR-1227
	High (n=16)	Low (n=12)	P value	High (n=9)	Low (n=19)
Characteristics
Age
>= 50	11(68.75%)	8 (66.6)	0.907	5 (55.55%)	12(63.15%)
<50	5 (31.25%)	4 (33.3)		4(44.45%)	7(36.85%)
Lymphatic metastasis
Yes	10(62.5%)	3(25%)	0.049*	3 (33.33%)	14 (73.68)
NO	6(37.5)	9(75%)		6(66.66%)	5 (26.31)
FIGO stage
I-II	9(56.25%)	2(16.6%)	0.033*	6 (66.66%)	7 (36.84%)
III-IV	7(43.75%)	10(83.4%)		3 (33.33%)	12 (63.16%)
Histological grade
G1	5(31.25%)	9 (75%)	0.022*	7 (77.77%)	6(31.58%)
G2+G3	11 (68.75)	3(25%)		2 (22.23)	13(68.42%)
Menstruation
Non-menopause	2(12.5%)	7(58.33)	0.012*	7 (77.77%)	5 (26.31%)
Menopause	14 (87.5%)	5 (41.66)		2 (22.23%)	14 (73.68)